Type II cGMP-dependent protein kinase inhibits ligand-induced activation of EGFR in gastric cancer cells

Molecular Medicine Reports

Volumn 9, Issue 4, 2014, Pages 1405-1409

  Jiang, Lu ^a   Chen, Yongchang ^a   Li, Yueying ^a   Lan, Ting ^a   Wu, Min ^a   Wang, Ying ^a   Qian, Hai ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Type ii cgmp dependent protein kinase, egf receptor, ligand, inhibition, gastric cancer cells

Indexed keywords

BETACELLULIN; CYCLIC GMP DEPENDENT PROTEIN KINASE 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; THREONINE; TRANSFORMING GROWTH FACTOR ALPHA; TYROSINE;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; INHIBITION KINETICS; PROTEIN PHOSPHORYLATION; STOMACH CANCER; WESTERN BLOTTING;

CELL LINE, TUMOR; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE II; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84896514499     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1942     Document Type: Article

References (38)

1. Shah MA and Schwartz GK: Treatment of metastatic esophagus and gastric cancer. Semin Oncol 31: 574-587, 2004. (Pubitemid 39089070)
2. Becker JC, Muller-Tidow C, Serve H, et al: Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol 12: 3297-3305. 2006. (Pubitemid 43933772)
3. Arnold D, Peinert S, Voigt W, et al: Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review. Oncologist 11: 602-611, 2006. (Pubitemid 43967615)
4. Johnston JB, Navaratnam S, Pitz MW, et al: Targeting the EGFR pathway for cancer therapy. Curr Med Chem 13: 3483-3492, 2006. (Pubitemid 44873742)
5. Astsaturov I, Cohen RB and Harari PM: EGFR-targeting monoclonal antibodies in head and neck cancer. Curr Cancer Drug Targets 6: 691-710, 2006. (Pubitemid 44875963)
6. Oda K, Matsuoka Y, Funahashi A and Kitano H: A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 1: 2005.0010, 2005.
7. Yarden Y and Shilo BZ: SnapShot: EGFR signaling pathway. Cell 131: 1018, 2007.
8. Arteaga CL: Overview of epidermal growth factor receptor biology and its role as therapeutic taget in human neoplasia. Semin Oncol 29: 3-9, 2002.
9. Krozely P: Epidermal growth factor receptor tyrosine kinase inhibitors: evolving role in the treatment of solid tumors. Clin J Oncol Nurs 8: 163-168, 2004.
10. Cook AL and Haynes JM: Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell Signal 16: 253-261, 2004.
11. Swartling FJ, Ferletta M, Kastemar M, et al: Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28: 3121-3131, 2009.
12. Fallahian F, Karami-Tehrani F, Salami S, et al: Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and-negative breast cancer cell lines. FEBS J 278: 3360-3369, 2011.
13. Swartling FJ, Ferletta M, Kastemar M, et al: Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28: 3121-3131, 2009.
14. Wang R, Kwon IK, Thangaraju M, et al: Type 2 cGMP-dependent protein kinase regulates proliferation and differentiation in the colonic mucosa. Am J Physiol Gastrointest Liver Physiol 303: G209-G219, 2012.
15. Chen YC, Ren F, Sang JR, et al: Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823. Mol Med Rep 3: 361-366, 2010.
16. Jiang L, Lan T, Chen Y, et al: PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells. PLoS One 8: e61674, 2013.
17. Wu Y, Chen Y, Qu R, et al: Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Oncol Rep 27: 553-558, 2012.
18. Lan T, Chen Y, Sang J, et al: Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells. Oncol Rep 27: 2039-2044, 2012.
19. Harris RC, Chung E and Coffey RJ: EGF receptor ligands. Exp Cell Res 284, 2-13, 2003. (Pubitemid 36331964)
20. Prigent SA and Lemoine NR: The type I (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 4: 1-24, 1992.
21. Barnard JA, Beauchamp RD, Russell WE, et al: Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108: 564-580, 1995.
22. D'Agnano I, D'Angelo C, Savarese A, et al: DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Invest 72: 432-438, 1995.
23. Wells A: EGF receptor. Int J Biochem Cell Biol 31: 637-643, 1999.
24. Takemura S, Yashiro M, Sunami T, et al: Novel models for human scirrhous gastric carcinoma in vivo. Cancer Sci 95: 893-900, 2004. (Pubitemid 40045524)
25. Wang C, Lv X, Jiang C, et al: Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways. PLoS One 7: e48299, 2012.
26. Dias A, Garcia C, Majewski M, et al: Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study. Dig Dis Sci 56: 3220-3225, 2011.
27. Yoshida K, Kyo E, Tsujino T, et al: Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res 81: 43-51, 1990. (Pubitemid 20070250)
28. Sasada R, Ono Y, Taniyama, Y, et al: Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem Biophys Res Commun 190: 1173-1179, 1993. (Pubitemid 23207889)
29. Dunbar AJ and Goddard C: Structure-function and biological role of betacellulin. Int J Biochem Cell Biol 32: 805-815, 2000. (Pubitemid 30625116)
30. Shing Y, Christofori G, Hanahan D, et al: Betacellulin: a mitogen from pancreatic beta cell tumors. Science 259: 1604-1607, 1993. (Pubitemid 23114638)
31. Seno M, Tada H, Kosaka M, et al: Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. Growth Factors 13: 181-191, 1996. (Pubitemid 26378938)
32. Toyoda H, Komurasaki T, Uchida D, et al: Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270: 7495-7500, 1995.
33. Toyoda H, Komurasaki T, Uchida D et al: Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 326: 69-75, 1997. (Pubitemid 27386919)
34. Das SK, Das N, Wang J, et al: Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the "window" of implantation. Dev Biol 190: 178-190, 1997. (Pubitemid 27488104)
35. Komurasaki T, Toyoda H, Uchida D, et al: Mechanism of growth promoting activity of epiregulin in primary cultures of rat hepatocytes. Growth Factors 20: 61-69, 2002. (Pubitemid 34823453)
36. Shirakata Y, Komurasaki T, Toyoda H, et al: Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 275: 5748-5753, 2000. (Pubitemid 30115217)
37. Rangaswami H, Marathe N, Zhuang S, et al : Type II cGMP-dependent protein kinase mediates osteoblast mechano-transduction. J Biol Chem 284: 14796-14808, 2009.
38. Nie HG, Chen L, Han DY, et al: Regulation of epithelial sodium channels by cGMP/PKGII. J Physiol 587: 2663-2676, 2009.